TAG HIV Basic Science, Vaccines, and Cure Project Blog
By Richard Jefferys, Project Director at Treatment Action Group (TAG).
recent posts
- In The News: CAR-T Cells for HIV
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the March 2026 Update
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the February 2026 Update
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the December 2025 and January 2026 Updates
- TAG’s HIV Cure-Related Clinical Research Listing: Background on the November 2025 Update
Category: Broadly neutralizing antibodies
-
The 25th International AIDS Conference is taking place in Munich, Germany from July 22-26, with several pre-conference events scheduled on Sunday, July 21st. Remote access will also be possible for registered attendees, with recordings made publicly available at some point after the meeting ends. Links to events and sessions related to HIV cure research are…
-
There are 14 updates in the June 2024 revision to TAG’s listing. New Additions Three newly registered studies have been added: two interventional and one observational. The German company Hookipa Biotech is sponsoring a clinical trial assessing two therapeutic HIV vaccine candidates based on an arenavirus vector platform in people with HIV on antiretroviral…
-
The April 2024 update to TAG’s listing features eight changes. New Additions Three new studies were added this month. All are protocols being initiated by the U.S. government-funded ACTG Network (formerly known as the AIDS Clinical Trials Group, recently revised to Advancing Clinical Therapeutics Globally). The Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa…
-
The March 2024 revision to TAG’s listing includes 26 updates. The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver from March 3-6, and the addition of links to results from HIV cure-related studies presented at the meeting typically makes this the busiest month for changes — hence the delay to this…
-
A total of eight changes were made to TAG’s listing for the first monthly update of 2024. New Additions One new study has been added from the Pan African Clinical Trials Registry: Scientists affiliated with the Centre for the AIDS Programme of Research in South Africa (CAPRISA) are launching a phase I cure-related trial investigating…
-
No new HIV cure-related trials or studies were added to the clinicaltrials.gov registry over the past month. A total of seven updates were made to TAG’s listing: A clinical trial in Barcelona, Spain investigating the effects of the drug dasatinib on HIV persistence and inflammation is now open for enrollment. Dasatinib is a tyrosine kinase…
-
No new HIV cure-related trials or studies were added to the clinicaltrials.gov registry over the past month. A total of eight updates have been made to TAG’s listing: A phase II study sponsored by AbbVie that was added to the listing in September (see prior blog update) is now open for enrollment. The company initiated…
-
There are twelve updates to the listing this month: four new interventional trials and one observational study have been added (all yet to start recruiting), a planned observational study was withdrawn, a trial of immunomodulators has begun recruiting in China, one trial has shifted to the completed studies table, and links to presentations/publications describing results…
-
The past month has seen few changes to TAG’s listing: since the previous update on June 15, two ongoing trials have closed to enrollment, one planned protocol has been withdrawn, and links have been added to three recently published papers presenting study results. For the second month in succession, no new HIV cure-related clinical studies…
-
March tends to be the busiest month for updates to TAG’s HIV cure-related clinical research listing because of results being presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI). Today’s update includes links to 30 abstracts from CROI 2023; posters can be downloaded from the abstract pages, but webcasts of oral presentations won’t…